Sheela Foam Q3 FY24 Earnings Call Analysis

- The company expects EBITDA margins to normalize around 12.5% in future quarters (Page 3). - Marketing expenses are anticipated to stabilize between 6% to 6.5%, down from the current higher levels, supporting margin improvement (Page 3). - Synergies from the Kurlon acquisition are beginning to show operational and procurement benefits, expected to positively impact bottom line progressively (Pages 11-13). - The mattress volume and revenue growth is supported by strong performance in Sleepwell brand and expansion into new segments like furniture, particularly in Australia (Pages 13-14). - Furlenco is on track to achieve profitability by February with EBITDA positivity from December; further growth expected as operations stabilize (Page 7). - Long-term ROE is projected to be in the range of 18%-20% after the acquisition and synergy benefits materialize (Page 8). - The company is confident of achieving higher market penetration and volume growth, especially through small town India focus and improved distribution (Pages 5, 9). Overall, the outlook is positive with improved profitability and earnings growth expected over the next quarters.

The transcript from the Sheela Foam Limited Q3 FY ‘24 Earnings Conference Call does not provide specific details regarding the current or expected order book or pending orders. There is no direct mention or discussion about order book status, pending orders, or their expectations in the provided pages of the transcript. The focus is mainly on financial performance, synergy realization post Kurlon acquisition, capacity expansion updates, marketing spends, geographic market performance (Australia, Spain, Europe), and profitability outlook. If you need detailed order book or pending orders data, it might require reaching out to the company's Investor Relations or looking at a more detailed operational or quarterly report outside this transcript.